Abstract
In congenital nephrogenic diabetes insipidus (NDI) blunted responses of plasma factor VIII, von Willebrand factor, and plasminogen activator to the synthetic V2 analogue 1-desamino-8-d-arginine vasopressin (DDAVP) have been reported. In addition, vasodilatory responses to DDAVP appear to be absent in NDI. We describe a boy, who presented shortly after birth with the typical features of NDI, but who showed normal coagulation, fibrinolytic and vasodilatory responses to DDAVP. We conclude that in this patient the defect is confined to the kidney, while in other NDI patients there may be a general V2 receptor abnormality. These findings point to heterogeneity in NDI.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- c-AMP:
-
cylic adenosine monophosphate
- DDAVP:
-
1-desamino-8-d-arginine vasopressin
- NDI:
-
nephrogenic diabetes insipidus
- t-PA:
-
tissue-type plasminogen activator
- vWF:ag:
-
von Willebrand factor antigen
References
Bia MJ, Dewitt S, Forrest JN (1979) Dissociation between plasma, urine, and renal papillary cyclic AMP content following vasopressin and DDAVP. Am J Physiol 277:F218-F225
Bichet DG, Razi M, Lonergan M, Arthrus MF, Papukna V, Kortas C, Bayon J-N (1988) Hemodynamic and coagulation responses to 1-desamino-[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus. N Engl J Med 318:81–87
Bode HH, Crawford JD (1969) Nephrogenic diabetes insipidus in North America — The Hopewell hypothesis. N Engl J Med 280:750–754
Brenner B, Seligsohn U, Hochberg Z (1988) Normal response of factor VIII and von Willebrand factor to 1-desamino-8D-argimne vasopressin in nephrogenic diabetes insipidus. J Endocrinol Metab 67:191–193
Brommer EJP, Brummelen P van, Derkx FHM (1984) Desmopressin and hypotension. Ann Intern Med 103:962
Cash JD, Gader AMA, Da Costa J (1974) The release of plasminogenactivator and fVIII by LVP, AVP, DDAVP, ATIII, and OT in man. Br J Haematol 27:363–364
Knoers N, Heyden H van der, Oost BA van, Monnens L, Willems J, Ropers HH (1988) Linkage of X-linked Nephrogenic diabetes insipidus with DXS52, a polymorphic DNA marker. Nephron 50:187–190
Knoers N, Heyden H van der, Oost BA van, Ropers HH, Monnens L, Willems J (1988) Nephrogenic diabetes insipidus: close linkage with markers from the distal long arm of the human X chromosome. Hum Genet 80:31–38
Knoers N, Brommer EJP, Willems J, Oost BA van, Monnens LAH (1990) Fibrinolytic responses to 1-desamino-8-d-arginine vasopressin in patients with congenital nephrogenic diabetes insipidus. Nephron 54:322–326
Kobrinski NL, Doyle JJ, Israel EDS, Winter JSD, Cheang MS, Walker RD, Bihof A (1985) Absent factor VIII response to synthetic vasopressin analogue in Nephrogenic diabetes insipidus. Lancet I:1293–1294
Lochrie MA, Simon MI (1988) G protein multiplicity in eukaryotic signal transduction systems. Biochemistry 27:4957–4965
Moses AM, Miller JL, Levine MA (1988) Two distinct pathophysiological mechanisms in congenital nephrogenic diabetes insipidus. J Clin Endocrinol Metab 66:1259–1264
Neer EJ, Clapham DE (1988) Roles of G protein subunits in transmembrane signaling. Nature 333:129–134
Ohzeki T (1985) Urinary adenosine 3′5′-monophosphate (c-AMP) response to antidiuretic hormone in diabetes insipidus (DI): comparison between congenital nephrogenic DI type 1 and 2, and vasopressin sensitive DI. Acta Endocrinol 108:485–490
Ohzeki T, Sunaguchi M, Tsunei M, Shinzawa T, Hanaki K, Shiraki K (1988) Coagulation factor responsiveness in nephrogenic diabetes insipidus. J Pediatr 113:790
Rijken DC, Hinsbergh VWM van, Lens EHC (1984) Quantification of tissue-type plasminogen activator in human endothelial cell cultures by use of an enzyme immunoassay. Thromb Res 33:145–153
Robinson MG, Kaplan SA (1960) Inheritance of vasopressin resistant (“nephrogenic”) diabetes insipidus. Am J Dis Child 99:164–174
Spiegel AM (1987) Signal transduction by guanine nucleotide binding proteins. Mol Cell Endocrinol 49:1–16
Spiegel AM, Levine MA, Aurbach GD, Brown RW, Marx SJ, Lasker RD, Moses AM, Breslan NA (1982) Deficiency of hormone receptor-adenylate cyclase coupling protein: basis for hormone resistance in pseudohypoparathyreoidism. Am J Physiol 243:37–42
Verheyen JH, Mullaert E, Chang GTG, Kluft C, Wijngaards G (1982) A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurement in plasma. Thromb Res 48:266–269
Williams RH, Henry C (1947) Nephrogenic diabetes insipidus: transmitted by females and appearing during infancy in males. Ann Int Med 27:84–95
Zimmerman D, Green OC (1975) Nephrogenic diabetes insipidus-type II: defect distal to the adenylate cyclase step. Pediatr Res 9:381
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Knoers, N., Monnens, L.A.H. A variant of nephrogenic diabetes insipidus: V2 receptor abnormality restricted to the kidney. Eur J Pediatr 150, 370–373 (1991). https://doi.org/10.1007/BF01955943
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01955943